Institution profile

医療法人インテグレス 大宮エヴァグリーンクリニック

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 01C2507040 +4

Location

Prefecture
Saitama
Address
さいたま市大宮区下町2丁目16-1 アクロスビル3F

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • JSCSF再生医療等委員会
  • ICTA特定認定再生医療等委員会

Public score

59.5/ 100

A · Review level
25.0 / 30
B · Technologies
20.6 / 35
C · Coverage
7.1 / 25
D · Class I / II technologies
6.7 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Overall ranking

No. 208of 1736

Registered technologies
5
Areas covered
2

Technology areas · Rank

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 59.5
Public score →100

Registered technologies (5)

Stem cells (all sources) 4
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来幹細胞を用いた慢性疼痛の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた糖尿病の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた慢性腎臓病の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いたED(勃起不全)の治療Stem cells (all sources)Adipose-derived stem cellsClass II
Adipose-derived stem cells 4
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来幹細胞を用いた慢性疼痛の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた糖尿病の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた慢性腎臓病の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いたED(勃起不全)の治療Stem cells (all sources)Adipose-derived stem cellsClass II
NK and immune cells 1
Registered technologies · Japanese originalTechnology areasPlan classification
ヒト自己活性化NK細胞による免疫細胞療法NK and immune cellsClass III

Certified committee for regenerative medicine

  • JSCSF再生医療等委員会
  • ICTA特定認定再生医療等委員会

Public document number

  • 01C2507040
  • 01C2602061
  • 01C2507041
  • 01C2510021
  • 03C2406024
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
自己脂肪由来幹細胞を用いた慢性疼痛の治療Class IIJSCSF再生医療等委員会01C2507040
自己脂肪由来幹細胞を用いた慢性腎臓病の治療Class IIJSCSF再生医療等委員会01C2602061
自己脂肪由来幹細胞を用いたED(勃起不全)の治療Class IIJSCSF再生医療等委員会01C2507041
自己脂肪由来幹細胞を用いた糖尿病の治療Class IIJSCSF再生医療等委員会01C2510021
ヒト自己活性化NK細胞による免疫細胞療法Class IIIICTA特定認定再生医療等委員会03C2406024

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor